DESCRIPTION: High precision radiotherapy robot CyberKnife is state-of-the-art technology that makes it possible to treat cancer and benign tumours in various parts of the body using outpatient care, painlessly, and with the possibility to returning to one’s usual rhythm of life as quickly as possible. It should be stressed that radiosurgery takes place without surgical intervention. The term “cyberknife” is used to characterise the precision of the method and the long-term effectiveness of therapy, which is equivalent to a surgical operation. This method can be used to treat primary tumours and metastases within the human body, including within the head, spine, prostate, liver, kidneys and elsewhere. Robotic radiosurgery can be combined with other tumour treatment methods such as surgery, radiotherapy and chemotherapy. Cyberknife is especially appropriate for treatment of tumours that are located in places that are hard to access, e.g. in the brain or spine, mobile organs and elsewhere. CyberKnife technology provides an automated patient movement monitoring system and synchronisation of radiation doses with breathing. The CyberKnife® M6 machine installed at the Sigulda Radiosurgery Centre is the latest model in the CyberKnife equipment series.
INDICATIONS: Patients with cancer, benign tumours and other illnesses that can be treated using radiosurgery or radiotherapy.
RESULT: During the procedure, tumour cells are not removed from the body, but their DNA is damaged by ionising radiation and the cells can no longer regenerate themselves. Over time, the damaged cancerous cells die and the body destroys them naturally. The cancerous cells are replaced by inactive cells – connective tissue or scar tissue.